STO introduces AstraZeneca products for chronic diseases
STO says that they have always worked to ensure that the medicines imported into Maldives are of good quality.
By
Aishath Fareeha Abdulla
STO on Saturday introduced products from AstraZeneca, one of the world's leading pharmaceutical companies, to Maldives.
This will strengthen the government's efforts to increase the assurance that medicines will be available for chronic diseases at a lower cost by working directly with the manufacturer, STO said.
STO will be the exclusive distributor of AstraZeneca's products in Maldives.
STO says that they have always worked to ensure that the medicines imported into Maldives are of good quality.
With the availability of products from a company like AstraZeneca, the public's confidence in the drugs provided by STO will increase, the company said.
-
Under the agreement with AstraZeneca, STO has registered 14 of its drugs for coverage under Aasandha
-
These include medications for cancer, gastritis, and diabetes
-
Under the agreement, the government's efforts to improve the health sector and STO's objectives will be achieved
STO aims to facilitate widespread access to quality pharmaceutical and healthcare products directly from pharmaceutical and healthcare manufacturers without any intermediaries.
STO has already signed agreements with 26 companies to import pharmaceuticals and health products directly from the companies.
